Form EFFECT Protara Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 22, 2026 9:30 A.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Reply and IEO Launch Collaboration to Co-Develop and Train Domain-Specific Large Language Models for Oncology
- Press Release: Sanofi launches 2026 global employee stock purchase plan
- Onchain Stocks Hit $5.5 Billion in Volume, Yet Most Trading Still Follows U.S. Market Hours, New Report Finds
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
